ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,848
Screening encounters
3,213
Diagnostic referrals
620
Outstanding pathways
240

Screening pathway

  1. Screening3,213Encounters
  2. Positive finding1,096Documented findings
  3. Referral620Diagnostic referrals
  4. Follow-up725Diagnostic visits
  5. Outcome380Resolved pathways

Stage totals use different units. Pending pathways: 240. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-05-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2848 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2056 · Expanded synthetic participant 2056Site B — Peri-Urban Access Programme
EXP-2057 · Expanded synthetic participant 2057Site C — Rural Outreach Programme
EXP-2058 · Expanded synthetic participant 2058Site D — Community Engagement Programme
EXP-2061 · Expanded synthetic participant 2061Site C — Rural Outreach Programme
EXP-2063 · Expanded synthetic participant 2063Site C — Rural Outreach Programme
EXP-2065 · Expanded synthetic participant 2065Site C — Rural Outreach Programme
EXP-2067 · Expanded synthetic participant 2067Site C — Rural Outreach Programme
EXP-2068 · Expanded synthetic participant 2068Site B — Peri-Urban Access Programme
EXP-2069 · Expanded synthetic participant 2069Site A — Urban Referral Hub
EXP-2070 · Expanded synthetic participant 2070Site E — Resource-Constrained Navigation Programme
EXP-2071 · Expanded synthetic participant 2071Site A — Urban Referral Hub
EXP-2073 · Expanded synthetic participant 2073Site D — Community Engagement Programme
EXP-2075 · Expanded synthetic participant 2075Site E — Resource-Constrained Navigation Programme
EXP-2076 · Expanded synthetic participant 2076Site B — Peri-Urban Access Programme
EXP-2077 · Expanded synthetic participant 2077Site C — Rural Outreach Programme
EXP-2078 · Expanded synthetic participant 2078Site B — Peri-Urban Access Programme
EXP-2079 · Expanded synthetic participant 2079Site A — Urban Referral Hub
EXP-2080 · Expanded synthetic participant 2080Site A — Urban Referral Hub
EXP-2084 · Expanded synthetic participant 2084Site E — Resource-Constrained Navigation Programme
EXP-2087 · Expanded synthetic participant 2087Site C — Rural Outreach Programme
EXP-2090 · Expanded synthetic participant 2090Site D — Community Engagement Programme
EXP-2091 · Expanded synthetic participant 2091Site A — Urban Referral Hub
EXP-2092 · Expanded synthetic participant 2092Site D — Community Engagement Programme
EXP-2095 · Expanded synthetic participant 2095Site D — Community Engagement Programme
EXP-2096 · Expanded synthetic participant 2096Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1301
HPV DNA
1440
Cytology
472

Navigation activity

Barrier documented
535
Contact attempt
917
Navigation intervention
231
Diagnostic booking
773
Diagnostic visit
725

Documented barriers

Contact difficulty
177
Transport difficulty
165
Appointment coordination
193

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.